• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[腹腔注射速尿对间歇性腹膜透析期间血浆中蛋白质水平及其可透析能力指标的影响]

[Effect of intraperitoneal furosemide administration on levels of +proteins+ in plasma and signs of their ability to be dialyzed during intermittent peritoneal dialysis].

作者信息

Grzegorzewska A, Krzymański M, Antoniewicz K

机构信息

Kliniki Nefrologii Instytutu Chorób Wewnetrznych AM im. K. Marcinkowskiego w Poznaniu.

出版信息

Pol Tyg Lek. 1991;46(4-5):67-70.

PMID:1845696
Abstract

The study aimed at evaluating an effect of intraperitoneal furosemide on plasma proteins such as albumins, globulins, IgG and IgA and their loss during dialysis. An experiment involved 18 patients with critical renal failure treated with intermittent peritoneal dialyses. Furosemide was administered intraperitoneally with dialysing fluid (40 mg/1) in a total dose of 240 mg. Each patient underwent 2 dialyses of 14 exchanges each. The first dialysis without furosemide served as a control of plasma protein loss during conventional dialysis with a fluid of 369 mOsm/kg at flow rate 2.4 l/hour. Furosemide was given during the second dialysis during three consecutive exchanges. An effect of furosemide on plasma proteins was compared with the results obtained before and after its administration. It was found that furosemide did not change plasma proteins levels and does not increase their loss during exchanges of dialysing fluid containing this drug; during dialysing fluid exchanges without furosemide some indices of IgG and IgA dialysis are significantly decreased due to an increase in ultrafiltration following furosemide cessation. It is important for the increase in intermittent peritoneal dialyses efficiency with the aid of furosemide that its short-term administration does not increase proteins loss during dialysis, if their molecular weight is not exceeding 69,000.

摘要

该研究旨在评估腹腔注射速尿对血浆蛋白(如白蛋白、球蛋白、IgG和IgA)的影响及其在透析过程中的丢失情况。实验涉及18例接受间歇性腹膜透析治疗的重症肾衰竭患者。速尿与透析液(40mg/1)腹腔内给药,总剂量为240mg。每位患者进行2次透析,每次14次交换。第一次无速尿透析作为常规透析(使用369mOsm/kg的液体,流速为2.4升/小时)期间血浆蛋白丢失的对照。在第二次透析的连续三次交换期间给予速尿。将速尿对血浆蛋白的影响与其给药前后获得的结果进行比较。发现速尿不会改变血浆蛋白水平,也不会增加在含有该药物的透析液交换过程中它们的丢失;在没有速尿的透析液交换过程中,由于速尿停用后超滤增加,IgG和IgA透析的一些指标显著降低。借助速尿提高间歇性腹膜透析效率很重要的一点是,如果蛋白质分子量不超过69,000,其短期给药不会增加透析过程中的蛋白质丢失。

相似文献

1
[Effect of intraperitoneal furosemide administration on levels of +proteins+ in plasma and signs of their ability to be dialyzed during intermittent peritoneal dialysis].[腹腔注射速尿对间歇性腹膜透析期间血浆中蛋白质水平及其可透析能力指标的影响]
Pol Tyg Lek. 1991;46(4-5):67-70.
2
[Levels of plasma proteins in patients with ene stage renal failure treated with peritoneal dialysis with an addition of furosemide to dialysis fluid].[在透析液中添加呋塞米进行腹膜透析治疗的终末期肾衰竭患者的血浆蛋白水平]
Pol Tyg Lek. 1994;49(6-7):137-40.
3
[Comparison of various pharmacologic and conventional methods of increasing the effectiveness of peritoneal dialysis. V. Usefulness of selected parameters of peritoneal transfer for evaluating the effectiveness of intermittent peritoneal dialysis].[各种增加腹膜透析有效性的药理学和传统方法的比较。V. 腹膜转运选定参数对评估间歇性腹膜透析有效性的有用性]
Przegl Lek. 1989;46(5):440-7.
4
[Estimation of hearing in patients with end stage renal failure being peritoneally dialyzed with and without furosemide in the dialysis fluid].[对接受腹膜透析的终末期肾衰竭患者在透析液中使用和不使用速尿时听力的评估]
Pol Tyg Lek. 1992;47(49-50):1087-9.
5
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
6
Effectiveness of furosemide in patients on peritoneal dialysis.速尿对腹膜透析患者的疗效。
CANNT J. 2006 Jul-Sep;16(3):40-4.
7
[Evaluation of loss of active heparin in the peritoneal cavity during intermittent peritoneal dialysis].[间歇性腹膜透析期间腹腔内活性肝素丢失的评估]
Pol Tyg Lek. 1992;47(5-6):123-5.
8
[Comparison of various pharmacologic and conventional methods of increasing the effectiveness of peritoneal dialysis. IV. A large intraperitoneal dose of furosemide in the modeling of continuous peritoneal dialysis].[增加腹膜透析效能的各种药理学及传统方法的比较。IV. 大剂量腹腔注射速尿在持续性腹膜透析模型中的应用]
Przegl Lek. 1988;45(11):770-5.
9
[Comparison of various pharmacological and conventional methods of increasing the effectiveness of peritoneal dialysis. I. Intraperitoneal or intravenous use of furosemide during intermittent peritoneal dialysis].[多种提高腹膜透析效果的药理学及传统方法的比较。I. 间歇性腹膜透析期间腹腔内或静脉注射呋塞米]
Przegl Lek. 1988;45(4):365-73.
10
[Effectiveness of peritoneal dialysis using dialysis fluid of modernized composition].[使用现代化成分透析液进行腹膜透析的有效性]
Wiad Lek. 1990 Jun 15;43(12):564-71.